Lymphomatoid papulosis : A Case Report

Authors

  • Watchai Mingbunjerdsuk DIVISION OF DERMATOLOGY, DEPARTMENT OF MEDICINE, FACULTY OF MEDICINE, CHULALONGKORN UNIVERSITY, BANGKOK, THAILAND
  • Nopadon Noppakun DIVISION OF DERMATOLOGY, DEPARTMENT OF MEDICINE, FACULTY OF MEDICINE, CHULALONGKORN UNIVERSITY, BANGKOK, THAILAND

Keywords:

Lymphomatoid papulosis, CD30 positive cutaneous lymphoproliferative disease

Abstract

Lymphomatoid papulosis is one of CD30 positive cutaneous lymphoproliferative diseases. The clinical presentation is recurrent reddish-brownish papulonodular lesions that tends to spontaneously regress leaving hyperpigmented scars. Lesions usually occur over the trunk and the extremities. There is an association between lymphomatoid papulosis and malignanancies.

We reported a 39-year-old man presenting with multiple  papulonodular lesions on his trunk and extremities. The histopathology revealed  dense dermal infiltration with  atypical monomorphous mononuclear cells that have pleomorphic large vesicular nuclei and some cells have hyperchromatic nuclei and atypical mitotic figure. The atypical cells expressed CD4 and CD30, suggesting the diagnosis of lymphomatoid papulosis. The lesions were spontaneously healed within 2 weeks.

References

Macaulay WL. Lymphomatoid papulosis: A continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol 1968;97:23-30.

el-Azhary RA, Gibson LE, Kurtin PJ, Pittelkow MR, Muller SA. Lymphomatoid papulosis: A clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies . J Am Acad Dermatol. 1994;30(2 Pt 1):210-8.

El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid Papulosis: reappraisal of Clinicopathologic Presentation and Classification Into

Subtypes A, B, and C. Arch Dermatol 2004;140:441-7.

Saggini A, Gulia A, Argenyi Z, at al. A Variant of Lymphomatoid Papulosis Simulating Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma. Description of 9 Cases.Am J Surg Pathol. 2010;34(8):1168-75.

De Souza A, Camilleri MJ, Wada DA, et al. Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients. J Am Acad Dermatol. 2009;61(6):993-1000.

Stein H, Foss HD, Dürkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96(12):3681-95.

Tan AW, Giam YC. Lymphomatoid papulosis associated with recurrent cutaneous T-cell lymphoma. Ann Acad Med Singapore. 2004;33(1):110-2.

Cabanillas F, Armitage J, Pugh WC, et al. Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Intem Med 1995;122: 210-7.

Kadin ME, Levi E, Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand. Ann NY Acad Sci 2001; 941: 59-68.

Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and othe primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 1996;34:470-81.

Marie-France D, Lynne JG, Marshall EK, Howard K. K:Is it lymphoma or lymphomatoid papulosis?. J Am Acad Dermatol 1997;36:765-772

Willemze R, Beljaards RC. Spectrum of primarycutaneous CD30 (Ki-1)-positive lymphoproliferativedisorders: A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993;28:973–980.

Downloads

Published

2026-06-11

How to Cite

Mingbunjerdsuk, W., & Noppakun, N. (2026). Lymphomatoid papulosis : A Case Report. Thai Journal of Dermatology, 27(2), 135–141. retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/282967

Issue

Section

Case Report